Literature DB >> 26620611

Prostate cancer: PD-L1 expression is common and indicates poor prognosis.

Clemens Thoma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26620611     DOI： 10.1038/nrurol.2015.287

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  The Immune Checkpoint Regulator PD-L1 Is Highly Expressed in Aggressive Primary Prostate Cancer.

Authors:  Heidrun Gevensleben; Dimo Dietrich; Carsten Golletz; Susanne Steiner; Maria Jung; Thore Thiesler; Michael Majores; Johannes Stein; Barbara Uhl; Stefan Müller; Jörg Ellinger; Carsten Stephan; Klaus Jung; Peter Brossart; Glen Kristiansen
Journal:  Clin Cancer Res       Date:  2015-11-16       Impact factor: 12.531
  1 in total
  6 in total

Review 1.  Prognostic Role of Programmed Death Ligand-1 Expression in Breast Cancer: A Systematic Review and Meta-Analysis.

Authors:  Xue Li; Minghuan Li; Zhen Lian; Hui Zhu; Li Kong; Ping Wang; Jinming Yu
Journal:  Target Oncol       Date:  2016-12       Impact factor: 4.493

2.  Prognostic value of programmed death-ligand 1 in sarcoma: a meta-analysis.

Authors:  Zhenhua Zhu; Zheng Jin; Mei Zhang; Yajun Tang; Guang Yang; Xiaowei Yuan; Jihang Yao; Dahui Sun
Journal:  Oncotarget       Date:  2017-07-11

3.  The values of neutrophil-lymphocyte ratio and/or prostate-specific antigen in discriminating real Gleason score ≥ 7 prostate cancer from group of biopsy-based Gleason score ≤ 6.

Authors:  Hanfeng Wang; Liangyou Gu; Yongjie Wu; Dan Feng; Junyao Duan; Xiaocong Wang; Yong Huang; Shengpan Wu; Jianwen Chen; Guangda Luo; Xu Zhang
Journal:  BMC Cancer       Date:  2017-09-06       Impact factor: 4.430

4.  Clinicopathological and prognostic significance of PD-L1 expression in sarcoma: A systematic review and meta-analysis.

Authors:  Chuanxi Zheng; Wei You; Peng Wan; Xiaochun Jiang; Jinquan Chen; Yuchen Zheng; Wei Li; Jifeng Tan; Shiquan Zhang
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

5.  Prognostic and Clinicopathological Value of Programmed Death Ligand-1 in Breast Cancer: A Meta-Analysis.

Authors:  Yawen Guo; Pan Yu; Zeming Liu; Yusufu Maimaiti; Shan Wang; Xingjie Yin; Chunping Liu; Tao Huang
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

6.  ATM/NEMO signaling modulates the expression of PD-L1 following docetaxel chemotherapy in prostate cancer.

Authors:  Zongren Wang; Xueling Zhang; Wuguo Li; Qiao Su; Zhaoyang Huang; Xinyao Zhang; Haiqi Chen; Chengqiang Mo; Bin Huang; Wei Ou; Junxing Chen; Guangyin Zhao; Lingwu Chen; Lan Shao
Journal:  J Immunother Cancer       Date:  2021-07       Impact factor: 13.751
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.